纳米微晶Y_2Sn_(2-x)FexO_(7-δ)的制备及其催化选择性能研究

采用共沉淀并加法制备了Ｂ位掺杂烧绿石型稀土复合氧化物纳米微晶Ｙ２Ｓｎ２－ｘＦｅｘＯ７－δ（ｘ＝００～１０）。制备的纳米微晶属于立方晶系，Ｆｄ３ｍ，晶胞参数与掺杂量呈线性关系。通过Ｍｓｂａｕｅｒ、ＴＧＤＴＡ，气相色谱和γ射线辐照等技术研究了纳米微晶对ＣＯ的催化选择性能。结果表明，纳米微晶对ＣＯ的催化选择性明显高于一般粉料对ＣＯ的选择性；纳米微晶对ＣＯ的选择性与掺杂量有关；未辐照的纳米微晶，当掺杂量ｘ＝０６时，其对ＣＯ的选择性为最高，辐照后的纳米微晶，当掺杂量ｘ＝０４时，其对ＣＯ的选择性为最高     

反相高效液相色谱柱前衍生荧光法测定肠粘膜中的谷氨酰胺

以邻苯二甲醛及３－巯基丙酸为衍生试剂,５０ｍｍｏｌ／Ｌ磷酸缓冲液（ｐＨ７．０）－乙腈（９４∶６,Ｖ／Ｖ）为流动相,在ＬｉｃｈｒｏｓｏｒｂＲＰ１８（１５０ｍｍ×４．６ｍｍｉ．ｄ．,５μｍ）柱上,研究并建立了测定动物肠粘膜中谷氨酰胺（Ｇｌｎ）的柱前衍生荧光ＲＰ－ＨＰＬＣ法。样品与衍生剂按４∶１进行衍生反应,Ｅｘ＝２３０ｎｍ,Ｅｍ＝３８９ｎｍ;流速为２．０ｍＬ／ｍｉｎ。Ｇｌｎ的保留时间为３．１５８ｍｉｎ,检测限为２５μｍｏｌ／Ｌ（Ｓ／Ｎ＝３．５）,线性范围为５０～３２００μｍｏｌ／Ｌ,ｒ＝０．９９９６。     

氧化物表面单层改性对SnO2超微粒子热稳定性的影响

研究了氧化物在气敏材料二氧化锡超细粉表面的分散行为及分散量的二氧化锡热稳定性的影响,结果表明,氧化铜,氧化镍,氧化铋和氧化锌在二氧化锡表面均能单层分散,分散阈值均与按密置单层模型计算的最大分散容量相符,负载二氧锡的表面覆盖度与其稳定性之间有很好的对应关系,单层覆盖率达到一定程度二氧化锡高温烧结便可基本得到抑制。     

扫描近场光学显微镜对纳米结构的观察

光学显微镜在人们认识微观世界的过程中一直扮演着非常重要的角色．随着认识的深入，对空间分辨率的要求也越来越高．但是众所周知，普通光学显微镜（远场情况下）的分辨率受光的衍射效应所限制，一般可表达为0．61A／N．A．（约等于A／2，A为照射光的波长，N．A．为数值孔径）     

MH—Ni电池封口化成及其性能

在硼氢化钾碱性溶液中对金属氢化物（ＭＨ）电极的表面进行化学还原处理，提高了ＭＨ电极的放电容量、活化性能和电催化活性．用其为负极组装的ＡＡ型ＭＨ－Ｎｉ电池进行了封口化成，电池放电容量达到１１５０ｍＡｈ，５Ｃ下电池的放电容量达到０．２Ｃ下容量的８０％以上，电池在１Ｃ１００％ＤＯＤ（放电深度）充放电条件下，循环寿命由原来的１００次左右提高到２００次以上     

纳米晶体材料研究进展

综述了目前纳米晶体材料合成、结构、性质和应用的研究和发展现状。通过惰性气体凝结、机械合金、等离子体技术和其他许多方法可以制得纳米晶体材料。尽管早期的研究者认为纳米晶体材料的晶粒边界结构不同于常规材料, 但目前有关纳米晶体材料结构的研究表明其具有与常规晶体材料相同的晶粒边界结构。纳米晶体材料所具有的诸如扩散和烧结、力学、陶瓷和金属间化合物的延展性、电学、热膨胀、光学、磁学、催化和腐蚀行为等性质优于常规多晶材料, 这些性质具有巨大的潜在应用价值。     

The Discovery of Actinospene,a New Polyene Macrolide with Broad Activity against Plant Fungal Pathogens and Pathogenic Yeasts

Phytopathogenic fungi infect crops, presenting a worldwide threat to agriculture. Polyene macrolides are one of the most effective antifungal agents applied in human therapy and crop protection. In this study, we found a cryptic polyene biosynthetic gene cluster in Actinokineospora spheciospongiae by genome mining. Then, this gene cluster was activated via varying fermentation conditions, leading to the discovery of new polyene actinospene (1), which was subsequently isolated and its structure determined through spectroscopic techniques including UV, HR-MS, and NMR. The absolute configuration was confirmed by comparing the calculated and experimental electronic circular dichroism (ECD) spectra. Unlike known polyene macrolides, actinospene (1) demonstrated more versatile post-assembling decorations including two epoxide groups and an unusual isobutenyl side chain. In bioassays, actinospene (1) showed a broad spectrum of antifungal activity against several plant fungal pathogens as well as pathogenic yeasts with minimum inhibitory concentrations ranging between 2 and 10 μg/mL.     

Screening of Potential Anti-Thrombotic Ingredients from Salvia miltiorrhiza in Zebrafish and by Molecular Docking

Background: Danshen (DS), the dry root of Salvia miltiorrhiza Bge., has been used in traditional Chinese medicine (TCM) for many years to promote blood circulation and to inhibit thrombosis. However, the active ingredients responsible for the anti-thrombotic effect and the underlying mechanisms are yet to be fully elucidated. Methods: Molecular docking was used to predict the active ingredients in DS and their potential targets by calculating the scores of docking between DS ingredients and thrombosis-related proteins. Then, a chemical-induced zebrafish thrombosis model was applied to confirm their anti-thrombotic effects. Result: The molecular docking results indicated that compared to the control ligand, higher docking scores were observed for several compounds in DS, among which salvianolic acid B (SAB), lithospermic acid (LA), rosmarinic acid (MA), and luteolin-7-O-β-d-glucoside (LG) could attenuate zebrafish caudal vein thrombosis and recover the decrease in heart red blood cells (RBCs) in a dose-dependent manner. Conclusions: Our study showed that it is possible to screen the potential active components in natural products by combining the molecular docking method and zebrafish in vivo model.     

Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the production of β2-glycoprotein I (β2GPI)-dependent autoantibodies, with vascular thrombosis or obstetrical complications. Around 20% of APS patients are refractory to current treatments. Crassolide, a cembranoid diterpene extracted from soft corals, is a potential therapeutic candidate. Here, to examine the anti-inflammatory properties of crassolide, we first determined its effects on bone marrow-derived and splenic dendritic cells (DC). Specifically, we applied lipopolysaccharide (LPS) or β2GPI stimulation and measured the expressions of CD80 and CD86, and secretions of cytokines. We also determined in the OT-II mice, if bone marrow-derived DC was able to stimulate antigen-specific T cells. Moreover, we examined the therapeutic potential of crassolide postimmunization in a murine model of APS that depended on active immunization with β2GPI. The vascular manifestations were evaluated in terms of fluorescein-induced thrombi in mesenteric microvessels, whereas the obstetric manifestations were evaluated based on the proportion of fetal loss after pregnancy. We also measured blood titers of anti-β2GPI antibody, splenic cell proliferative responses and cytokine secretions after β2GPI stimulation ex vivo. Finally, we determined in these mice, hematological, hepatic and renal toxicities of crassolide. Crassolide after LPS stimulation suppressed DC maturation and secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-12 and IL-23, and downstream T cell activation. Crassolide could partially ameliorate both the vascular and obstetric manifestations of APS in BALB/c mice. Both blood titers of anti-β2GPI antibody and splenic cell proliferation after β2GPI stimulation were reduced. Splenic Th1 and Th17 responses were also lowered after β2GPI stimulation. Finally, within therapeutic doses of crassolide, we found no evidence of its toxicity. In conclusion, we showed the ability of crassolide to suppress DC and downstream T cell responses. Crassolide is therefore a potential candidate for adjunctive therapy in APS.